Furthermore, tissue-resident memory T cells co-expressing PD-1 and TIGIT in endometrial cancer show reduced cytotoxicity and tumor targeting; yet, they paradoxically maintain enhanced proliferation, potentially contributing to their persistence within the tumor. The gene discussed is TIGIT; the disease is endometrial cancer.